Key result
Modern pharmacoinvasive strategy for rural STEMI shows no in-hospital major cardiovascular events benefit over the premodern era.
Why the study?
Have in-hospital outcomes for rural STEMI patients treated with a pharmacoinvasive strategy improved in the modern era compared to the premodern era?
Cohort (n=2,228)
Yes
Have in-hospital outcomes for rural STEMI patients treated with a pharmacoinvasive strategy improved in the modern era compared to the premodern era?
Answers are grounded in this paper and cite their sources.
In a rural STEMI network, in-hospital outcomes for patients treated with a pharmacoinvasive strategy have remained largely unchanged over the past two decades despite improvements in care delivery metrics.
Background Geographic challenges complicate treatment of rural patients with ST-elevation myocardial infarction (STEMI), and many undergo a pharmacoinvasive (PI) strategy for optimal STEMI management. The PI population remains vastly understudied in contemporary interventional cardiology practice. This study sought to evaluate the changing comorbidities, clinical characteristics, treatment strategies and in-hospital outcomes over a twenty-year period between the premodern era (2001-2012) and the modern era (2013-2020) of patients who underwent a PI strategy for STEMI. Methods All patients presenting with a STEMI and treated with a PI strategy within the Dartmouth-Health regional STEMI network over a 20-year period were retrospectively analyzed. Patients were stratified to the premodern era (2000-2012) or the modern era (2013-2020), and patient-level data were compared between eras. Two coprimary outcomes of in-hospital major adverse cardiac events (death, recurrent myocardial infarction, ischemic stroke, and hemorrhagic stroke) and bleeding complications were compared between eras. Results Despite an increase in the global burden of cardiovascular comorbidities over the past 2 decades, comorbidities remained constant in this patient population over time. In contrast with the observed temporal improvements in STEMI outcomes in urban populations, adjusted in-hospital MACE (7.2% vs 6.9%, P = .76) and bleeding rates (8.0% vs 7.0%, P = .4) were similar between STEMI patients treated with a PI strategy in the premodern and modern era. Conclusions In a large cohort of rural STEMI patients treated with a PI strategy over the past 20 years, care delivery metrics improved, while in-hospital outcomes remained largely unchanged over time. This presents a target for future strategies to improve cardiovascular care in rural patient populations.
No takes yet. Share an insight, caveat, or question.
Rothstein et al. (2026) conducted a cohort in ST-elevation myocardial infarction (STEMI) (n=2,228). Modern era (2013-2020) pharmacoinvasive strategy vs. Premodern era (2001-2012) pharmacoinvasive strategy was evaluated on In-hospital major adverse cardiac events (MACE) (OR 1.147, 95% CI 0.812-1.620, p=0.44). In rural STEMI patients treated with a pharmacoinvasive strategy, in-hospital major cardiovascular events rates remained similar between the modern and premodern eras despite improvements in care delivery metrics.
Synapse has enriched 10 related papers. Consider them for comparative context: